Advertisement

Product › Details
mass spec test, brain damage, proteomic, blood-based
![]() |
Next higher product group | clinical mass spectrometry-based proteomic test |
Record changed: 2023-07-10 |
Advertisement

More documents for clinical mass spectrometry-based proteomic test
- [1] Proteomedix AG. (5/26/20). "Press Release: Proteomedix Appoints Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD as Medical Advisor". Zürich-Schlieren....
- [2] Proteomedix AG. (5/19/20). "Press Release: Analytical Performance of Proclarix Verified". Zürich-Schlieren....
- [3] Proteomedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür...
- [4] Proteomedix AG. (1/10/20). "Press Release: Proteomedix Appoints Helge Lubenow as New CEO". Zürich-Schlieren....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top